Though there were no differences between ZAG expression and secretion in cancer cell lines, we hypothesized that secretion might be altered in vivo (potentially due to deglycosylation).
We measured ZAG levels in the sera of PDAC patients (n¼16) and healthy volunteers (n¼14) revealing no significant differences between the groups (Figure 2d).